This inventor holds 1 USPTO granted patent. Top assignee: Crispr Therapeutics Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heidi Heath and Her Patent on ALAS1 Gene Expression
Introduction
Heidi Heath is an inventor associated with South Boston, Massachusetts. Her patent work includes an invention concerning the modulation of expression of the ALAS1 (5'-aminolevulinate synthase 1) gene.
Latest Patents
Heath is listed as an inventor on 1 patent: “Modulating Expression of ALAS1 (5'-Aminolevulinate Synthase 1) Gene.” The patent addresses modulation of gene expression and is associated with Crispr Therapeutics AG.
Career Highlights
The available information connects Heath’s inventive work with Crispr Therapeutics AG and research involving ALAS1 gene expression. These details provide a focused view of her documented patent activity.
Collaborations
Heath’s listed coworkers include Mary-Lee Dequeant and Rachel Yuen. Their names indicate professional connections associated with the information provided, though specific roles in the patent are not stated.
Conclusion
Heidi Heath’s documented innovation centers on a patent concerning the modulation of ALAS1 gene expression, reflecting her connection to biotechnology research and Crispr Therapeutics AG.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
